Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson’s disease
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 145, 112479
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (19K21225)
- Japan Society for the Promotion of Science (20K18476)
This publication has 57 references indexed in Scilit:
- Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1PLOS ONE, 2013
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseNeurobiology of Disease, 2011
- Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in RatsStroke, 2011
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and InfectionAnnual Review of Immunology, 2011
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive NeurodegenerationJournal of Neuroscience, 2011
- The Contribution of Spinal Glial Cells to Chronic Pain Behaviour in the Monosodium Iodoacetate Model of Osteoarthritic PainMolecular Pain, 2011
- Pain in Parkinson’s disease: Prevalence and characteristicsPain, 2009
- Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in ratsThe FASEB Journal, 2007
- Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's diseaseMovement Disorders, 2004
- P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injuryNature, 2003